摘要
肌少症是一种进行性和全身性的骨骼肌疾病,是慢性阻塞性肺疾病(COPD)的重要肺外合并症。多项研究已证实合并肌少症的COPD患者气流阻塞和肺气肿程度更为严重、呼吸困难指数评分更高、生活质量和运动能力下降、频繁急性加重率和病死率升高。肌少症虽然作为COPD的合并症被提及多年,但目前的临床实践对其关注度和干预均不足,究其原因主要是其发病机制不明,药物治疗方案效果不佳所致。随着近年来对COPD合并肌少症的研究越来越多,本文对现阶段COPD合并肌少症的研究进展包括发病率、对临床结局的影响、发病机制、诊断标准和治疗进展进行综述,望能为COPD合并肌少症深入研究及早期干预提供一定的参考价值。
Sarcopenia is a progressive and systemic skeletal muscle disease and an important extrapulmo⁃nary complication of chronic obstructive pulmonary disease(COPD).Multiple studies have confirmed that COPD patients with sarcopenia have more severe airflow obstruction and emphysema,higher dyspnea index scores,reduced quality of life and exercise capacity,frequent acute exacerbations,and increased mortality.Although sarcopenia has been mentioned as a complication of COPD for many years,current clinical practice has received insufficient attention and insufficient intervention.The main reason is that its pathogenesis is unknown and drug treatment regi⁃mens are ineffective.As more and more research has been done on COPD combined with sarcopenia in recent years,this article reviews the current research progress to pay attention to further research and early intervention,including new mechanisms,diagnostic criteria,and drug treatment progress.
作者
杨士芳
高兴林
李静
姬路鹏
YANG Shifang;GAO Xinglin;LI Jing;JI Lupeng(Department of Pulmonary and Critical Care Medicine,Guangdong Provincial People′s Hospital,Guang-dong Academy of Medical Sciences,Southern Medical University,Guangzhou 510080,China;不详)
出处
《实用医学杂志》
CAS
北大核心
2024年第9期1181-1185,共5页
The Journal of Practical Medicine
基金
中华国际医学交流基金会呼吸疾病青年实用研究项目(编号:Z2017242301)。
关键词
慢性阻塞性肺疾病
肌少症
进展
chronic obstructive pulmonary disease
sarcopenia
progress
